Sigmoid Pharma, formerly known as Sigmoid Biotechnologies, is a privately-held, biopharmaceutical development company developing a portfolio of innovative and proprietary orally administered pharmaceutical products in the areas of transplantation, gastro-intestinal disease and neuro-degeneration.